This Week in Nephrology — Jul 8, 2026

Welcome to This Week in Nephrology. This week we are covering ten notable papers spanning advancements in glomerular disease biomarkers and therapies, practical dietary and metabolic management in chronic kidney disease, and critical clinical updates…

This week's papers: 1. Pivotal Clinical Trials in C3 Glomerulopathy: answers and remaining uncertainties. — Nephrology, dialysis, transplantation 2026 2. Randomized Crossover Trial of Low Sodium Dialysate on Tissue Sodium Accumulation in Hemodialysis. — Kidney international reports 2026 3. Effect of Semaglutide on Measured vs Estimated Glomerular Filtration Rate. — Nephrology, dialysis, transplantation 2026 4. Circulating Antinephrin Antibodies in Adult Chinese Patients With IgAN and Nephrotic-Range Proteinuria. — Kidney international reports 2026 5. Ultrasensitive Immunoassay Using a Novel Galactose-Deficient IgA1 Antibody and Its Clinical Application in the Diagnosis of IgAN. — Kidney international reports 2026 6. Severe Pregnancy-Associated Acute Kidney Injury and Maternal Vulnerability. — Nephrology, dialysis, transplantation 2026 7. Approach to Hyperkalemia: The Role of Diet and Pharmacological Therapies. — American journal of kidney diseases 2026 8. High Protein Diets: What to Tell Our Patients. — American journal of kidney diseases 2026 9. Impact of immunosuppressive therapy on renal and patient survival in rapidly progressive secondary IgA nephropathy. — Nephrology, dialysis, transplantation 2026 10. Evidence-Based Medicine versus Personalized Medicine when attempting to block complement in IgA nephropathy. — Nephrology, dialysis, transplantation 2026

Listen at https://audioscholar.cc/episode/w4m44w7mgx